跳至主要内容
临床试验/NCT02884505
NCT02884505已完成不适用

Improving the Assessment of Hypersomnolence

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2017年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
132
试验地点
1
主要终点
Proportion of Patients Categorized with Hypersomnolence

研究概览

简要总结

The overall purpose of this study is to employ a pragmatic, multidimensional assessment of hypersomnolence that "piggybacks" on routine clinical care in patients with suspected disorders of central nervous system (CNS) hypersomnia, to determine whether these additional objective and subjective assessments are useful in the diagnosis and management of these patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-89
  • Referred for polysomnography/multiple sleep latency test at Wisconsin Sleep, the sleep medicine clinic and laboratory of the University of Wisconsin-Madison

排除标准

  • unstable medical condition that, in the opinion of the investigators, would make it unsafe for the subject to participate

结局指标

主要结局

Proportion of Patients Categorized with Hypersomnolence

时间窗: 2 Years

Multiple measurements will be aggregated to arrive at the primary outcome of proportion of patients categorized as having hypersomnolence using either standard assessments or standard assessments plus additional novel hypersomnolence measures of pupillometry, psychomotor vigilance task, and auditory evoked potentials. Proportion of patients with hypersomnolence using standard measures will be calculated as number of patients with mean sleep latency (MSL) on multiple sleep latency test (MSLT) \<8 minutes divided by total number of patients. Proportion of patients categorized as having hypersomnolence with additional novel hypersomnolence measures will be calculated as the number of patients with MSL\<8 minutes, and/or pupillary unrest index (PUI) \>8.9 on pupillometry, and/or PVT lapses \>3, and/or P300 delay/sleep negativity during auditory evoked potentials divided by total number of patients.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验